Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1503.3000 15.30 (1.03%)

NSE Sep 30, 2025 15:31 PM

Volume: 1.0M

Cipla Ltd.

30 Oct 2024, 12:00AM

1503.30

1.03%

Cipla (SELL): No meaningful incremental triggers until Goa plant clearance

Sell: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Earnings in line with our estimates on all fronts. However, US sales was down and 5% lower than our estimates in rupee terms

Cipla Ltd. has an average target of 1702.60 from 10 brokers.